Greenleaf Trust cut its stake in The Sherwin-Williams Company (NYSE:SHW - Free Report) by 32.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,078 shares of the specialty chemicals company's stock after selling 5,914 shares during the period. Greenleaf Trust's holdings in Sherwin-Williams were worth $4,218,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently modified their holdings of the stock. Coppell Advisory Solutions LLC raised its stake in shares of Sherwin-Williams by 2.7% in the fourth quarter. Coppell Advisory Solutions LLC now owns 1,146 shares of the specialty chemicals company's stock worth $388,000 after acquiring an additional 30 shares during the last quarter. Opal Wealth Advisors LLC raised its stake in shares of Sherwin-Williams by 4.2% in the first quarter. Opal Wealth Advisors LLC now owns 791 shares of the specialty chemicals company's stock worth $276,000 after acquiring an additional 32 shares during the last quarter. Ashton Thomas Securities LLC raised its stake in shares of Sherwin-Williams by 1.5% in the fourth quarter. Ashton Thomas Securities LLC now owns 2,228 shares of the specialty chemicals company's stock worth $757,000 after acquiring an additional 34 shares during the last quarter. YANKCOM Partnership raised its stake in shares of Sherwin-Williams by 8.8% in the first quarter. YANKCOM Partnership now owns 420 shares of the specialty chemicals company's stock worth $147,000 after acquiring an additional 34 shares during the last quarter. Finally, Avantax Planning Partners Inc. raised its stake in shares of Sherwin-Williams by 2.4% in the fourth quarter. Avantax Planning Partners Inc. now owns 1,515 shares of the specialty chemicals company's stock worth $515,000 after acquiring an additional 35 shares during the last quarter. 77.67% of the stock is owned by institutional investors.
Sherwin-Williams Stock Performance
Shares of SHW opened at $345.98 on Wednesday. The company has a debt-to-equity ratio of 1.90, a quick ratio of 0.45 and a current ratio of 0.77. The Sherwin-Williams Company has a twelve month low of $297.86 and a twelve month high of $400.42. The firm's 50 day moving average price is $351.46 and its two-hundred day moving average price is $347.93. The firm has a market cap of $86.70 billion, a P/E ratio of 32.70, a PEG ratio of 3.11 and a beta of 1.18.
Sherwin-Williams (NYSE:SHW - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The specialty chemicals company reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $2.23 by $0.02. Sherwin-Williams had a net margin of 11.63% and a return on equity of 71.86%. The firm had revenue of $5.31 billion for the quarter, compared to analyst estimates of $5.42 billion. During the same quarter in the previous year, the firm posted $2.17 earnings per share. The business's revenue was down 1.1% on a year-over-year basis. On average, analysts forecast that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.
Sherwin-Williams Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 6th. Stockholders of record on Friday, May 16th were given a $0.79 dividend. This represents a $3.16 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date was Friday, May 16th. Sherwin-Williams's dividend payout ratio is presently 29.87%.
Analyst Upgrades and Downgrades
A number of equities analysts have weighed in on SHW shares. Royal Bank Of Canada boosted their target price on shares of Sherwin-Williams from $410.00 to $420.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Wells Fargo & Company upgraded shares of Sherwin-Williams from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $350.00 to $420.00 in a research report on Wednesday, April 30th. Mizuho set a $395.00 price target on shares of Sherwin-Williams in a research report on Tuesday, April 15th. Bank of America lifted their price target on shares of Sherwin-Williams from $289.00 to $296.00 and gave the stock an "underperform" rating in a research report on Monday, June 23rd. Finally, UBS Group lowered their price target on shares of Sherwin-Williams from $430.00 to $400.00 and set a "buy" rating for the company in a research report on Monday, April 7th. One research analyst has rated the stock with a sell rating, six have given a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Sherwin-Williams has a consensus rating of "Moderate Buy" and a consensus price target of $391.31.
Get Our Latest Stock Report on Sherwin-Williams
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.